Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1951 6
1952 3
1953 1
1954 1
1955 3
1956 6
1957 6
1958 5
1959 6
1960 5
1961 4
1962 7
1963 6
1964 14
1965 24
1966 18
1967 18
1968 11
1969 17
1970 23
1971 20
1972 32
1973 24
1974 26
1975 66
1976 80
1977 77
1978 94
1979 82
1980 107
1981 161
1982 117
1983 112
1984 156
1985 125
1986 128
1987 224
1988 131
1989 164
1990 253
1991 180
1992 160
1993 232
1994 174
1995 252
1996 152
1997 170
1998 230
1999 145
2000 154
2001 234
2002 134
2003 654
2004 818
2005 777
2006 796
2007 585
2008 527
2009 478
2010 458
2011 442
2012 502
2013 684
2014 845
2015 926
2016 915
2017 833
2018 820
2019 938
2020 94599
2021 142050
2022 131586
2023 89812
2024 26247
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

446,120 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean coronavirusfor covid or covid-19 or sars-cov-2 (428,483 results)?
Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan.
Hanatani JI, Kitagawa K, Tomooka F, Asada S, Mitoro A, Fujinaga Y, Nishimura N, Sato S, Shibamoto A, Fujimoto Y, Kubo T, Iwai S, Tsuji Y, Namisaki T, Akahane T, Kaji K, Tanaka M, Koizumi A, Yorioka N, Matsuda T, Masuda H, Takami M, Kikuchi M, Kawanishi M, Ohoka K, Watanabe D, Kawasaki A, Yoshiji H. Hanatani JI, et al. DEN Open. 2024 Apr 30;5(1):e371. doi: 10.1002/deo2.371. eCollection 2025 Apr. DEN Open. 2024. PMID: 38694541 Free PMC article.
OBJECTIVES: This study aimed to determine the impact of the coronavirus disease 2019 (COVID-19) pandemic on the treatment of acute cholangitis caused by choledocholithiasis. METHODS: The Japanese government declared a state of emergency in April 2020 due to t …
OBJECTIVES: This study aimed to determine the impact of the coronavirus disease 2019 (COVID-19) pandemic on the treatme …
COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia.
Tsega TD, Kebede AM, Dessie TM, Adane B, Yalew M, Ahmed AF, Mehari MG, Bayeh GM, Yeshiwas AG, Yizengaw MA, Alene T, Aynalem ZB. Tsega TD, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2350815. doi: 10.1080/21645515.2024.2350815. Epub 2024 May 17. Hum Vaccin Immunother. 2024. PMID: 38757639 Review.
COVID-19 vaccine acceptance is crucial for patients with chronic diseases, but previous studies in Ethiopia have yielded inconsistent and inconclusive findings. ...Based on these results, we recommend that healthcare professionals, policymakers, and healthcare guide
COVID-19 vaccine acceptance is crucial for patients with chronic diseases, but previous studies in Ethiopia have yielded incon
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H. Mimura W, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2350091. doi: 10.1080/21645515.2024.2350091. Epub 2024 May 17. Hum Vaccin Immunother. 2024. PMID: 38757631
Although previous studies have shown no increased mortality risk after the primary series of COVID-19 mRNA vaccines, reports on booster doses are lacking. This study aimed to evaluate mortality risk after the mRNA vaccine boosters in addition to the primary series. …
Although previous studies have shown no increased mortality risk after the primary series of COVID-19 mRNA vaccines, reports o …
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen.
Ahuja R, Vishwakarma P, Raj S, Kumar V, Khatri R, Lohiya B, Saxena S, Kaur G, Singh G, Asthana S, Ahmed S, Samal S. Ahuja R, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2351664. doi: 10.1080/21645515.2024.2351664. Epub 2024 May 17. Hum Vaccin Immunother. 2024. PMID: 38757508
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal beta-coronavirus that emerged in 2012. ...However, the ongoing effort is challenging due to conformational instability of the spike protein and the evasion strategy posed by the MERS-CoV
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal beta-coronavirus that emerged in 2012. ...However, …
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.
Bianchi FP, Polignano M, Carella N, Rotolo O, Curlo M, Mastronardi M. Bianchi FP, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2349319. doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16. Hum Vaccin Immunother. 2024. PMID: 38755111 Review.
Our study aims to assess COVID-19 VH among a global population of patients with IBD and to investigate the role of healthcare professionals, particularly gastroenterologists, in promoting immunization. Twenty-six studies were systematically selected from scientific …
Our study aims to assess COVID-19 VH among a global population of patients with IBD and to investigate the role of healthcare …
Human vaccines and immunotherapeutics: News April 2024.
Ellis R, Weiss A. Ellis R, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2354154. doi: 10.1080/21645515.2024.2354154. Epub 2024 May 16. Hum Vaccin Immunother. 2024. PMID: 38754020 No abstract available.
Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported cases.
Zeng Y, Du Z, Shao C, Zhao M. Zeng Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2350812. doi: 10.1080/21645515.2024.2350812. Epub 2024 May 16. Hum Vaccin Immunother. 2024. PMID: 38752704
Considering the widespread use of COVID-19 vaccines as a preventive measure against the spread of the virus, it's necessary to direct attention to the adverse effects associated with vaccines in a limited group of populations. Multiple evanescent white dot sy …
Considering the widespread use of COVID-19 vaccines as a preventive measure against the spread of the virus, it's neces …
Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring.
Portilho AI, Hermes Monteiro da Costa H, Grando Guereschi M, Prudencio CR, De Gaspari E. Portilho AI, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2346963. doi: 10.1080/21645515.2024.2346963. Epub 2024 May 15. Hum Vaccin Immunother. 2024. PMID: 38745461
COVID-19, caused by SARS-CoV-2, and meningococcal disease, caused by Neisseria meningitidis, are relevant infectious diseases, preventable through vaccination. ...Here, we evaluated in mice the humoral and cellular immune response to different d
COVID-19, caused by SARS-CoV-2, and meningococcal disease, caused by Neisseria meningitidis, are relevant
Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly.
Kwon SL, Kim SY, Song M, Lee HM, Ban SH, Lee MS, Jeong H. Kwon SL, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2346966. doi: 10.1080/21645515.2024.2346966. Epub 2024 May 13. Hum Vaccin Immunother. 2024. PMID: 38741240 Free PMC article.
This research examines the low rate of co-administration of influenza and COVID-19 vaccines among seniors aged 65 and older in Korea, despite recommendations from authorities and academia worldwide. The study aimed to understand the influence of general chara …
This research examines the low rate of co-administration of influenza and COVID-19 vaccines among seniors aged 65 and o …
Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study.
Wu W, Zheng X, Ding H, Miao T, Zang Y, Shen S, Gao Y. Wu W, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2345505. doi: 10.1080/21645515.2024.2345505. Epub 2024 May 9. Hum Vaccin Immunother. 2024. PMID: 38724010 Free PMC article.
The potential impact of combined COVID-19 and influenza vaccination on long COVID remains uncertain. ...Our study might provide a strategy for people aged 50 and over to reduce the occurrence of long COVID, that is, to combine the use of the COVID
The potential impact of combined COVID-19 and influenza vaccination on long COVID remains uncertain. ...Our study might …
446,120 results
You have reached the last available page of results. Please see the User Guide for more information.